Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Johannesburg - Delayed Quote ZAc

Labat Africa Limited (LAB.JO)

Compare
6.00
-2.00
(-25.00%)
At close: February 21 at 4:48:19 PM GMT+2
Loading Chart for LAB.JO
DELL
  • Previous Close 8.00
  • Open 7.00
  • Bid 6.00 x --
  • Ask 8.00 x --
  • Day's Range 6.00 - 7.00
  • 52 Week Range 0.07 - 13.00
  • Volume 462,845
  • Avg. Volume 596,866
  • Market Cap (intraday) 54.775M
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) --
  • EPS (TTM) -0.04
  • Earnings Date Dec 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 21, 1992
  • 1y Target Est --

Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis and information technology products. The company was incorporated in 1986 and is based in Roodepoort, South Africa.

www.labat.co.za

43

Full Time Employees

May 31

Fiscal Year Ends

Recent News: LAB.JO

View More

Performance Overview: LAB.JO

Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

LAB.JO
14.29%
All Share Index
5.73%

1-Year Return

LAB.JO
8,471.43%
All Share Index
21.75%

3-Year Return

LAB.JO
2,207.69%
All Share Index
17.72%

5-Year Return

LAB.JO
1,100.00%
All Share Index
55.07%

Compare To: LAB.JO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LAB.JO

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    54.77M

  • Enterprise Value

    65.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.80

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -53.17%

  • Return on Assets (ttm)

    -13.02%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    48.54M

  • Net Income Avi to Common (ttm)

    -25.8M

  • Diluted EPS (ttm)

    -0.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.03M

  • Total Debt/Equity (mrq)

    365.53%

  • Levered Free Cash Flow (ttm)

    8.59M

Research Analysis: LAB.JO

View More

Company Insights: LAB.JO

Research Reports: LAB.JO

View More

People Also Watch